Hypocalcaemia (low serum calcium found)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First-line tests
Fasting laboratory tests
- Serum calcium
- Serum albumin
- PTH (on the same sample as the serum calcium)
- PTH, reimbursed in France (hypocalcaemia after thyroidectomy, or dialysis patient)if neededAfter thyroidectomy (diagnosis and follow-up of hypoparathyroidism) or in dialysis patients, PTH falls within the NABM indications of procedure 0983: do not write “NR” (not reimbursable in France); in other situations, use the previous line (NR) [2].
- Serum magnesium
- Serum phosphate
- Serum creatinine with eGFR
- 25-hydroxyvitamin D (reimbursed in France)
- Alkaline phosphatase (if osteomalacia suspected)if needednon-French guidelineSuspected osteomalacia (long-standing vitamin D deficiency) [1].
- Serum lipase (if abdominal pain, pancreatitis suspected)if needednon-French guidelineAbdominal pain suggesting acute pancreatitis, a cause of hypocalcaemia [3].
- Creatine kinase (CK) (if rhabdomyolysis suspected)if needednon-French guidelineSuspected rhabdomyolysis, a cause of hypocalcaemia [3].
- Ionised calcium (if hypoalbuminaemia or acid-base disorder; not reimbursed in France, rarely feasible in the community)if neededIn case of doubt (hypoalbuminaemia, acidosis or alkalosis); sample without tourniquet, anaerobic, transported on ice; not reimbursed in primary care [2,4].
24-hour urine collection
- Urinary calciumif neededSymptomatic adult whose treatment must start quickly: urinary calcium and creatinine on a spot sample, measured without waiting for fasting; the 24-hour collection then helps adjust treatment but must not delay it [4].
- Urinary creatinine on a urine sampleif neededSymptomatic adult whose treatment must start quickly: urinary calcium and creatinine on a spot sample, measured without waiting for fasting; the 24-hour collection then helps adjust treatment but must not delay it [4].
- Urinary calciumif neededAdult without symptoms (or whose treatment can wait): 24-hour urine collection in the absence of treatment, urinary creatinine checking that the collection is complete [4].
- 24-hour urinary creatinineif neededAdult without symptoms (or whose treatment can wait): 24-hour urine collection in the absence of treatment, urinary creatinine checking that the collection is complete [4].
Recheck after correcting hypomagnesaemia
Fasting laboratory tests
- Serum calcium
- Serum albumin
- Serum magnesium
- PTH (on the same sample as the serum calcium)
Sources (10)
- Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemia. BMJ. 2008;336(7656):1298-302.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 0578 (calcium), 0999 (gaz du sang), 0983 (parathormone) et 1139 (25-OH-vitamine D).
- Turner J, Gittoes N, Selby P; Society for Endocrinology Clinical Committee. Society for Endocrinology endocrine emergency guidance: Emergency management of acute hypocalcaemia in adult patients. Endocr Connect. 2016;5(5):G7-G8 (addendum : Endocr Connect. 2019;8(6):X1).
- Haute Autorité de santé, Centre de référence des maladies rares du métabolisme du calcium et du phosphate. Protocole national de diagnostic et de soins (PNDS) : Hypoparathyroïdie. Mars 2025.
- ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit MOPRAL 20 mg (oméprazole), rubriques 4.4 et 4.8, consulté le 11 octobre 2026.
- Agence européenne des médicaments. Prolia (dénosumab) : résumé des caractéristiques du produit (information produit EPAR), rubrique 4.4, consulté le 11 octobre 2026.
- Agence européenne des médicaments. Aclasta (acide zolédronique) : résumé des caractéristiques du produit (information produit EPAR), rubriques 4.3 et 4.4, consulté le 11 octobre 2026.
- North Midlands and Cheshire Pathology Service (University Hospitals of North Midlands NHS Trust). Adult Hypocalcaemia Primary Care Guidance. Version 1, novembre 2025 (guide local britannique).
- Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2022;186(2):R33-R63.
- U.S. Food and Drug Administration. FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab). Drug Safety Communication, 19 janvier 2024.